SM 5887;(7S,9S)-9-Acetyl-9-amino-7-(2-deoxy-β-D-erythro-pentopyranosyloxy)-6,11-dihydroxy-5,7,8,9,10,12-hexahydro-5,12-naphthacenedione·hydrochloride;Amrubicin hydrochloride;Calsed;BHMLHEQFWVQAJS-IERVSNJOSA-N;AMR hydrochloride;(1S,3S)-3-Acetyl-3-amino-5,12-dihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tetracenyl2-deoxy-β-D-erythro-pentopyranosidehydrochloride(1:1)
Amrubicin hydrochloride is a novel, fully synthetic anthracycline-class antineoplastic agent developed by Dainippon Sumitomo Pharma, used for the treatment of malignant tumors. It and its active metabolite, amrubicinol, exert antitumor effects primarily by inhibiting topoisomerase II activity, leading to DNA strand breaks and suppression of tumor cell proliferation.